VE/VCO2 IS A POWERFUL PREDICTOR OF MORTALITY IN WILD-TYPE TRANSTHYRETIN AMYLOIDOSIS

Authors :: Gheorghe Doros
Ivan Luptak
Adil Yunis
Lawreen H. Connors
Flora Sam
Source :: Journal of the American College of Cardiology. 69:830
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.
Abstract: Background: Wild-type transthyretin amyloidosis (ATTRwt) results in a progressive cardiomyopathy (CMY). The utility of cardiopulmonary exercise testing (CPX) in determining prognosis in ATTRwt CMY is unknown. Given the recent emergence of novel drug therapies to treat ATTRwt, we investigated the

Full Text Access

Tools